Atlas Trials

A Clinical Study to Evaluate the Safety and Efficacy of Anti-human CD 7 CAR-NK Cell Injection in Subjects With Relapsed and Refractory CD7-positive Hematological Malignancy

Clinical trial NCT07117175 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07117175
Sponsor
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Status
NOT_YET_RECRUITING
Phase
Early Phase 1
Study type
INTERVENTIONAL
ImmunologyHematologic MalignanciesCAR-NK
Start date
2025-09-01
Primary completion
2027-12-15
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.